Challenging the Narrative: Pharmaceutical Innov...

By João L. Carapinha

October 27, 2025

Pharmaceutical innovation funding in the UK faces scrutiny amid industry claims that low NHS spending deters investments, but this narrative overlooks key drivers like scientific talent, tax incentives, and operational efficiencies rather than dru...
Datroway TNBC Therapy: Transforming First-Line Treatment for Metastatic Tripl...
Lurbinectedin SCLC Therapy: FDA Approval and Its Economic Implications
Biosimilars Market Trends 2025: Understanding Erosion and Growth
Transforming Cancer Treatment: Implications of Subcutaneous Pembrolizumab App...
NICE Kidney Cancer Guideline: Enhancing Biopsy Use to Minimize Unnecessary Su...
Innovative Strategies of MoonLake Immunotherapeutics HS in Targeting Inflamma...
NICE Endorses Breakthrough Bladder Cancer Treatment for Enhanced Survival
Key Decisions on Health Technology Assessment at ACP124: Implications for Rar...
Most Expensive Drugs 2025: Trends and Implications in US Pharma Pricing
PADCEV KEYTRUDA Urothelial Cancer: Advancements in Survival Outcomes and Econ...
Donanemab Alzheimer’s Approval: A New Era in Treatment
Talquetamab Multiple Myeloma: Impact, Evidence, and Policy Considerations